Status:

COMPLETED

HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma

Lead Sponsor:

Assaf-Harofeh Medical Center

Conditions:

Fibromyalgia

Chronic Pain Syndrome

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on 2 types of patients' population suffering from chronic pain syndrome (Fibromyalgia): patients with history of psyc...

Detailed Description

This study is a prospective clinical trial. After signing a written informed consent, all patients will be invited to medical evaluation including pain sensitivity examination and a series of question...

Eligibility Criteria

Inclusion

  • Females
  • Age over 18
  • Known fibromyalgia (chronic pain syndrome) for more than 1 year

Exclusion

  • Any past hyperbaric treatment prior to inclusion
  • Patients with chest x-ray pathology incompatible with hyperbaric environment
  • Patients with middle ear problems
  • Patients, who cannot "pump", equals middle ear pressure, effectively
  • Patients who suffer from claustrophobia
  • Inability or Refusing to sign the Informed Consent Form

Key Trial Info

Start Date :

December 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2017

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03376269

Start Date

December 1 2014

End Date

November 1 2017

Last Update

July 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assaf-Harofeh Medical Center

Ẕerifin, Israel, 70300